EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Products and Antimicrobial Nanoparticles Against Methicillin-Resistant Staphylococcus aureus: Mechanisms, Synergistic Interactions, and Therapeutic Potential

Abdulaziz M Almuzaini iD, Mahmoud Jaber, Ayman Elbehiry iD

Pharmaceutics · 23.04.2026 · 18 (5) · 515

DOI: 10.3390/pharmaceutics18050515 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 23.04.2026. Verfasst von Abdulaziz M Almuzaini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Preventive Medicine, College of Veterinary Medicine, Qassim University, Buraydah 51452, Saudi Arabia. Die Arbeit nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus (MRSA) is a major clinical problem due to its resistance, virulence, and biofilm formation, which diminish antibiotic efficacy. This review explores natural products and antimicrobial nanoparticles (NPs) as alternative and combined strategies for controlling MRSA. Natural compounds, such as plant metabolites, essential oils, antimicrobial peptides, and fungal products, act by disrupting membranes, interfering with cellular processes, and limiting biofilm formation. Antimicrobial NPs, especially metal and metal oxide materials, act through membrane damage, oxidative stress, and metal ion release, enabling activity against resistant bacteria and improving biofilm penetration. Combining natural products with NPs increases stability, delivery, and local activity, enhances antibacterial effects, and reduces effective doses. Green synthesis enables direct integration of bioactive compounds, while nano-delivery platforms optimize solubility and controlled release. Nanotechnology-based applications such as wound dressings, nanocarriers, and multifunctional platforms support localized and sustained treatment and promote tissue repair. Despite these advances, clinical use is still constrained by safety concerns, variability in NP properties, and the lack of standardized evaluation and regulatory frameworks. Overall, combining natural products with antimicrobial NPs offers a practical strategy to augment MRSA treatment, but further progress depends on consistent design, robust safety evaluation, and clinical translation.

Schlagwörter

Stichwörter der Autor:innen

antibiotic resistanceantimicrobial nanoparticlesbiofilmdrug deliverymethicillin-resistant Staphylococcus aureusnanocarriersnatural productssynergistic therapy

Autor:innen und Institutionen

  • Department of Veterinary Preventive Medicine, College of Veterinary Medicine, Qassim University, Buraydah 51452, Saudi Arabia.
  • Department of Public Health, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah 51452, Saudi Arabia.

ORCID-Profile: Abdulaziz M Almuzaini, Ayman Elbehiry

Zitieren

APA

Almuzaini, A. M., Jaber, M., & Elbehiry, A. (2026). Natural Products and Antimicrobial Nanoparticles Against Methicillin-Resistant Staphylococcus aureus: Mechanisms, Synergistic Interactions, and Therapeutic Potential. Pharmaceutics, 18(5), 515. https://doi.org/10.3390/pharmaceutics18050515

Vancouver

Almuzaini AM, Jaber M, Elbehiry A. Natural Products and Antimicrobial Nanoparticles Against Methicillin-Resistant Staphylococcus aureus: Mechanisms, Synergistic Interactions, and Therapeutic Potential. Pharmaceutics. 2026;18(5):515. doi:10.3390/pharmaceutics18050515

BibTeX
@article{Almuzaini2026,
  author = {Almuzaini, Abdulaziz M and Jaber, Mahmoud and Elbehiry, Ayman},
  title = {Natural Products and Antimicrobial Nanoparticles Against Methicillin-Resistant Staphylococcus aureus: Mechanisms, Synergistic Interactions, and Therapeutic Potential},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {515},
  doi = {10.3390/pharmaceutics18050515}
}
Kostenlos starten →